Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Virtual Event

Jun 14, 2020 9:00 AM - Jun 18, 2020 5:00 PM

(Eastern Standard Time)

Fort Washington, PA 19034

DIA 2020 Global Annual Meeting

ON DEMAND - Global Commission Harnessing Cutting-Edge Technology to Accelerate Diagnosis of Rare Diseases in Children

Session Chair(s)

Gregory  Moore, MD, PhD

Gregory Moore, MD, PhD

Corporate Vice President, Health Technology and Alliances

Microsoft, United States

The Global Commission is committed to accelerating the time to diagnosis for children with a rare disease by leveraging proof-of-concept pilot projects which harness technology to create a connected patient journey. Accompanied by a demonstration.

Learning Objective : Describe the impact of the diagnostic odyssey affecting patients with a rare disease and the resulting global health issue for patients struggling to navigate complex health systems; Explain the technological pilots the Global Commission is committed to supporting, as well as how the group can accelerate time to diagnosis for rare disease patients and empower patients and their families.

Speaker(s)

Donatello  Crocetta, MD, MBA

Panelist

Donatello Crocetta, MD, MBA

Takeda Pharmaceuticals International Gmbh, Switzerland

Global Medical Head, Rare Immunology and Rare Metabolic Franchises

Gregory  Moore, MD, PhD

Panelist

Gregory Moore, MD, PhD

Microsoft, United States

Corporate Vice President, Health Technology and Alliances

Marshall Lynn Summar, MD

Panelist

Marshall Lynn Summar, MD

Children's National Medical Center, United States

Division Chief, Genetics and Metabolism; Director, Rare Disease Institute

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.